(lp0
S"Orexigen Therapeutics Announces Commercialization and Distributorship ... PR Newswire  - Mar 27, 2017 SAN DIEGO, March 27, 2017 /PRNewswire/ -- Orexigen Therapeutics, Inc.  today announced that its wholly owned subsidiary, Orexigen Therapeutics Ireland Ltd.Earnings Reaction History: Orexigen Therapeutics, Inc., 75.0% Follow-Through ... - NasdaqOrexigen Therapeutics'  CEO Mike Narachi on Q4 2016 Results - Earnings ... - Seeking Alpha"
p1
aS"Blame This for Orexigen Therapeutics, Inc.'s Mind-Numbingly Bad 2015 Motley Fool - Jan 8, 2016 Shares of Orexigen Therapeutics , a biotechnology company focused on the development of therapies to induce weight loss, collapsed 72% in 2015, based on data from S&amp;P Capital IQ."
p2
aS'Orexigen Therapeutics to Present at the 35th Annual JP Morgan Healthcare ... PR Newswire  - Dec 19, 2016 SAN DIEGO, Dec. 19, 2016 /PRNewswire/ -- Orexigen Therapeutics, Inc.  today announced that the company will present at the 35th Annual J.P. Morgan Healthcare Conference 2017 in San Francisco. The presentation is scheduled for&nbsp;...'
p3
aS'Orexigen Therapeutics Announces Commercialization and Distributorship ... PR Newswire  - Dec 8, 2016 SAN DIEGO, Dec. 8, 2016 /PRNewswire/ -- Orexigen Therapeutics, Inc.  today announced that its wholly owned subsidiary Orexigen Therapeutics Ireland Ltd.'
p4
aS'Orexigen Therapeutics Announces Commercialization and Distributorship ... PR Newswire  - Aug 1, 2016 SAN DIEGO, Aug. 1, 2016 /PRNewswire/ -- Orexigen Therapeutics, Inc.  today announced that wholly owned subsidiary Orexigen Therapeutics Ireland Ltd.'
p5
aS'Orexigen Therapeutics Announces Commercialization and Distributorship ... PR Newswire  - Aug 30, 2016 SAN DIEGO, Aug. 30, 2016 /PRNewswire/ -- Orexigen Therapeutics, Inc.  today announced that Valeant Canada, a subsidiary of Valeant Pharmaceuticals International, Inc., or its affiliates, will commercialize Contrave (naltrexone HCl&nbsp;...Orexigen Shares Up 14% After Commercialization, Distribution Deal With Valeant ... - BenzingaOrexigen Therapeutics, Inc.  Finds Partner To Share Burden Of ... - Scibility Media'
p6
aS'Orexigen Therapeutics Announces Commercialization and Distributorship ... PR Newswire  - Dec 19, 2016 SAN DIEGO, Dec. 19, 2016 /PRNewswire/ -- Orexigen Therapeutics, Inc.  today announced that its wholly owned subsidiary Orexigen Therapeutics Ireland Ltd.'
p7
aS'Orexigen Therapeutics Launches &quot;Brains Behind Weight Loss,&quot; a Dynamic Patient ... PR Newswire  - Jan 4, 2017 SAN DIEGO, Jan. 3, 2017 /PRNewswire/ -- Orexigen Therapeutics, Inc.  unveiled &quot;Brains Behind Weight Loss,&quot; a new, national direct-to-consumer advertising campaign demonstrating to patients how the brain plays an important role in weight&nbsp;...'
p8
aS'Company Outlook on Orexigen Therapeutics, Inc.  : Analyst ... The Herald - 9 hours ago Out of the 1 covering Street analysts offering stock ratings for Orexigen Therapeutics, Inc. , 0 have shares pegged as a Strong Buy while 0 analysts have the stock rated a Buy.'
p9
aS"Orexigen Therapeutics Announces Stockholder Approval of All Proposals at 2016 ... PR Newswire  - Jul 8, 2016 The Board of Directors and stockholders approved a 1-for-10 reverse stock split of all of the outstanding shares of Orexigen's common stock. The Company expects that shares of Orexigen will begin trading on a post-split basis on July 12, 2016. At the ..."
p10
a.